[go: up one dir, main page]

BR0013385A - Composições farmacêuticas para administração oral e tópica - Google Patents

Composições farmacêuticas para administração oral e tópica

Info

Publication number
BR0013385A
BR0013385A BR0013385-0A BR0013385A BR0013385A BR 0013385 A BR0013385 A BR 0013385A BR 0013385 A BR0013385 A BR 0013385A BR 0013385 A BR0013385 A BR 0013385A
Authority
BR
Brazil
Prior art keywords
oral
compounds selected
fatty acid
pharmaceutical compositions
topical administration
Prior art date
Application number
BR0013385-0A
Other languages
English (en)
Inventor
Tomaz Andrysek
Milan Struchlik
Ales Vrana
Alexandr Jegorov
Josef Struchlik
Vladimir Matha
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0013385(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galena As filed Critical Galena As
Publication of BR0013385A publication Critical patent/BR0013385A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES FARMACêUTICAS PARA ADMINISTRAçãO ORAL E TóPICA". Um método para aumentar a viscosidade de uma formulação farmacêutica para administração oral ou tópica compreende as etapas de combinar a) uma quantidade efetiva de um ou mais ingredientes ativos hidrófobos; b)5 a 50% de um ou mais compostos selecionados dentre ésteres de poliglicerol de ácidos graxos com 6-15 unidades glicerol; c) 5 a 50% de um ou mais compostos selecionados dentre ésteres de poliglicerol de ácidos graxos e/ou ácidos graxos insaturados com 2-12 unidades de glicerol; d) 5 a 50% de um ou mais compostos selecionados dentre ésteres de macrogol glicerol triglicerídeos, glicerídeos parciais ou ácidos graxos ou ésteres de macrogol de ácidos graxos e concorrentemente a relação entre componentes b) e c) é de 0,1 : 1 a 10: 1, e em que quando da diluição com água 1:1 em volume, a viscosidade da formulação aumenta em pelo menos 5 vezes em comparação com a composição não diluída.
BR0013385-0A 1999-08-17 2000-08-17 Composições farmacêuticas para administração oral e tópica BR0013385A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (1)

Publication Number Publication Date
BR0013385A true BR0013385A (pt) 2002-05-07

Family

ID=10859192

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013385-0A BR0013385A (pt) 1999-08-17 2000-08-17 Composições farmacêuticas para administração oral e tópica

Country Status (40)

Country Link
US (1) US20070190132A1 (pt)
EP (2) EP1210119B1 (pt)
JP (2) JP2003507343A (pt)
KR (2) KR100828747B1 (pt)
CN (2) CN1382061A (pt)
AR (2) AR025324A1 (pt)
AT (2) ATE402691T1 (pt)
AU (1) AU777740B2 (pt)
BR (1) BR0013385A (pt)
CA (2) CA2380951C (pt)
CO (1) CO5380014A1 (pt)
CY (1) CY1105318T1 (pt)
CZ (2) CZ296170B6 (pt)
DE (2) DE60018081T2 (pt)
DK (2) DK1334717T3 (pt)
EE (2) EE04955B1 (pt)
EG (1) EG23994A (pt)
ES (2) ES2311077T3 (pt)
GB (1) GB2355656B (pt)
HK (1) HK1049629A1 (pt)
HR (1) HRP20020154B1 (pt)
HU (1) HUP0203236A3 (pt)
IL (4) IL148200A0 (pt)
JO (1) JO2324B1 (pt)
MX (1) MXPA02001631A (pt)
NO (2) NO20020760L (pt)
NZ (1) NZ517271A (pt)
PE (1) PE20010636A1 (pt)
PL (1) PL192769B1 (pt)
PT (2) PT1210119E (pt)
RU (2) RU2279894C2 (pt)
SA (1) SA00210487B1 (pt)
SG (1) SG143019A1 (pt)
SI (1) SI1210119T1 (pt)
SK (2) SK2482002A3 (pt)
TN (1) TNSN00173A1 (pt)
UA (2) UA72539C2 (pt)
UY (1) UY26303A1 (pt)
WO (1) WO2001012229A1 (pt)
ZA (2) ZA200308221B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
CN100337620C (zh) * 2002-12-04 2007-09-19 日清药业股份有限公司 含有辅酶q10的水溶性组合物
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
US8236286B2 (en) * 2004-10-20 2012-08-07 Kao Corporation Liquid compositions for the oral cavity
CN101160118A (zh) * 2005-02-24 2008-04-09 依兰药物国际有限公司 多西紫杉醇或其类似物的纳米微粒制剂
EA201100863A1 (ru) * 2008-11-28 2011-12-30 Эдванс Холдингз Лимитед Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена
SI2405892T1 (sl) * 2009-03-12 2013-06-28 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Farmacevtska formulacija, ki obsega ketoprofen in polioksialkilenski ester hidroksimaščobne kisline
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
US9867769B2 (en) 2015-03-27 2018-01-16 Arch Personal Care Products, Lp Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
JPWO2023214509A1 (pt) * 2022-05-02 2023-11-09
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
US6008192A (en) * 1997-03-12 1999-12-28 Abbott Laboratories Hydrophilic binary systems for the administration of lipophilic compounds
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
BR9811058A (pt) * 1997-07-29 2000-09-05 Upjohn Co Formulação auto-emulsificante para compostos lipofìlicos
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
PT1334717E (pt) 2008-10-09
PL353445A1 (en) 2003-11-17
AR043106A2 (es) 2005-07-20
SI1210119T1 (en) 2005-06-30
CZ2002575A3 (cs) 2003-05-14
IL148200A0 (en) 2002-09-12
EP1210119B1 (en) 2005-02-09
GB2355656A (en) 2001-05-02
SA00210487B1 (ar) 2006-09-10
HUP0203236A3 (en) 2004-06-28
CZ296591B6 (cs) 2006-04-12
TNSN00173A1 (en) 2005-11-10
KR20020059367A (ko) 2002-07-12
PE20010636A1 (es) 2001-06-02
DE60018081T2 (de) 2006-01-05
EP1334717A2 (en) 2003-08-13
PL192769B1 (pl) 2006-12-29
CA2380951C (en) 2010-03-23
NO20034778D0 (no) 2003-10-24
EE04954B1 (et) 2008-02-15
CA2452118A1 (en) 2001-02-22
DK1210119T3 (da) 2005-06-20
EP1334717B1 (en) 2008-07-30
AU777740B2 (en) 2004-10-28
EE200300371A (et) 2003-10-15
JO2324B1 (en) 2005-09-12
PT1210119E (pt) 2005-05-31
DK1334717T3 (da) 2008-11-24
EE200200075A (et) 2003-04-15
CY1105318T1 (el) 2010-03-03
US20070190132A1 (en) 2007-08-16
JP2004238399A (ja) 2004-08-26
RU2003133451A (ru) 2005-04-20
CO5380014A1 (es) 2004-03-31
ES2237443T3 (es) 2005-08-01
GB2355656B (en) 2004-04-07
EE04955B1 (et) 2008-02-15
HRP20020154B1 (en) 2006-07-31
ATE288766T1 (de) 2005-02-15
ES2311077T3 (es) 2009-02-01
EP1334717A3 (en) 2004-01-02
ZA200201315B (en) 2004-06-30
SK286083B6 (sk) 2008-03-05
NO20020760D0 (no) 2002-02-15
DE60018081D1 (de) 2005-03-17
IL148200A (en) 2007-12-03
NZ517271A (en) 2004-02-27
SG143019A1 (en) 2008-06-27
KR20050095651A (ko) 2005-09-29
HK1049629A1 (zh) 2003-05-23
UY26303A1 (es) 2001-03-16
CZ296170B6 (cs) 2006-01-11
ZA200308221B (en) 2004-09-29
UA75926C2 (en) 2006-06-15
HRP20020154A2 (en) 2003-12-31
GB9919288D0 (en) 1999-10-20
RU2279895C2 (ru) 2006-07-20
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
NO20020760L (no) 2002-04-16
SK2482002A3 (en) 2002-12-03
HUP0203236A2 (hu) 2003-01-28
EP1210119A1 (en) 2002-06-05
DE60322454D1 (de) 2008-09-11
AR025324A1 (es) 2002-11-20
RU2279894C2 (ru) 2006-07-20
CN1382061A (zh) 2002-11-27
CA2380951A1 (en) 2001-02-22
UA72539C2 (en) 2005-03-15
IL158108A0 (en) 2004-03-28
ATE402691T1 (de) 2008-08-15
JP2003507343A (ja) 2003-02-25
KR100828748B1 (ko) 2008-05-09
EG23994A (en) 2008-03-10
MXPA02001631A (es) 2003-07-14
WO2001012229A1 (en) 2001-02-22
CN101406453A (zh) 2009-04-15
IL158108A (en) 2010-04-15
AU6461300A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
BR0013385A (pt) Composições farmacêuticas para administração oral e tópica
BR9810866A (pt) Composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos
DK1073415T3 (da) Gelerbare farmaceutiske sammensætninger
ES2164339T3 (es) Composiciones farmaceuticas para administracion oral que contienen hormonas sexuales.
DK1313510T3 (da) Injicerbar farmaceutisk sammensætning til systemisk administration af farmakologisk aktive aktivstoffer indeholdende middelkædede triglycerider
BR9811058A (pt) Formulação auto-emulsificante para compostos lipofìlicos
KR890001521A (ko) 서방형 신규 제약 제제물
UA102478C2 (en) Capsule composition
UY27320A1 (es) Nuevas composiciones farmacéuticas
KR840006440A (ko) 국소 외용 약학적 조성물의 제조방법
PL177592B1 (pl) Kompozycja farmaceutyczna lub weterynaryjna w postaci kremu
DK0456764T3 (da) Omega-3-fedtsyreholdig fedtemulsion til endotracheal indgift, fremstilling og anvendelse heraf
US5472705A (en) Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections
RU2008105323A (ru) Консервирующая композиция для офтальмологического применения
RU2233152C1 (ru) Крем противовоспалительного и противозудного действия для лечения дерматологических заболеваний
EP0684042A3 (en) Solid oral pharmaceutical preparation with gemfibrozil as an active ingredient and manufacturing method.
RU2133603C1 (ru) Крем для рук "мария"
RU2002127759A (ru) Фармацевтическая композиция, обладающая противовоспалительным и антиаллергическим действием
JP2021006521A5 (pt)
JPH11199493A (ja) 皮膚外用剤組成物
UY28008A1 (es) Composiciones farmacéuticas para administración oral y tópica
JP2010001218A (ja) 皮膚外用組成物および皮膚再生促進剤
SE8401748D0 (sv) Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans
BR9908132A (pt) Composição farmacêutica lìquida para administração oral

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: IVAX-CR A.S. (CZ)

Free format text: ALTERADO DE: GALENA AS

B25D Requested change of name of applicant approved

Owner name: IVAX PHARMACEUTICALS S.R.O. (CZ)

Free format text: ALTERADO DE: IVAX-CR A.S.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.